Protein decoys may battle COVID-19 and more.

Service, Robert F

Service, Robert F.

Science ; 379(6631): 427-428, 2023 02 03.

Article in English | MEDLINE | ID: covidwho-2245063

ABSTRACT

ABSTRACT

Drugs designed to resemble viruses' cellular targets move into clinical trials.

Subject(s)

Angiotensin-Converting Enzyme 2; Biomimetic Materials; COVID-19 Drug Treatment; COVID-19; Humans; Drug Design; Angiotensin-Converting Enzyme 2/chemistry; Angiotensin-Converting Enzyme 2/therapeutic use; Protein Domains; Protein Binding

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomimetic Materials / Angiotensin-Converting Enzyme 2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Science Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google